Importing and Exporting Medicinal Products in Switzerland

4 minLast updated: Back to the hub

Short answer

Importing ready-to-use medicinal products requires a licence and, in addition, that the product is authorised in Switzerland or an exception applies. From the EEA, release there can be relied on; from third countries, full testing must be demonstrated.

What two questions determine the import route?

First: is the product authorised in Switzerland? Without authorisation, import is only possible through an exception. Second: does it come from the EEA or a third country? That determines the effort for batch release and the testing evidence required.

Import scenarios and their requirements
ScenarioLicenceBatch releaseNote
Authorised product from the EEAImport licenceReliance on EEA release possibleDocument equivalence
Authorised product from a third countryImport licenceDemonstrate full testing in CH or the EEACheck import testing
Unauthorised product, individual patientImport by a healthcare professionalnot applicableArt. 49 MPLO, documented indication
Unauthorised product, trialImport licence plus trial authorisationGMP release of the investigational productObserve the HRA and Clinical Trials Ordinance
Parallel import of an authorised productImport plus simplified authorisationRepackaging requires a licenceArt. 14 para. 2 TPA
Export from SwitzerlandExport licencedepends on the destination countryExport certificates from Swissmedic

How does batch release work on import?

Every batch placed on the Swiss market needs release by a Responsible Person. Where the batch originates in the EEA, release there can be relied on if a contract and the equivalence of controls are documented. From third countries, identity and content testing in Switzerland or the EEA is required.

  1. Check and document the supplier's origin and licensing status.
  2. Conclude a quality agreement with the manufacturer and the releasing site.
  3. Evidence the GMP status of the manufacturing site, with inspection evidence for third countries.
  4. Check batch documentation and certificates of analysis before every release.
  5. Assess transport conditions and temperature data for every shipment.
  6. Document the Responsible Person's release decision.

What applies to individual imports of unauthorised medicinal products?

Under Art. 49 MPLO, healthcare professionals may import unauthorised medicinal products in small quantities for individual patients where no equivalent authorised medicinal product is available. The import must be documented, and responsibility for use stays with the healthcare professional.

  • Only by doctors or pharmacists holding a licence to practise.
  • Small quantities for a specific patient.
  • No equivalent medicinal product authorised in Switzerland available.
  • Authorised in a country of origin with comparable medicinal product control.
  • Documentation of the source, batch and recipient.
  • No advertising and no sale to third parties.

What is needed for export?

Export requires an export licence within the licence scope. Many destination countries additionally require official documents: a Certificate of a Pharmaceutical Product under the WHO scheme, a free-sale certificate, or a GMP confirmation. Swissmedic issues these certificates on request.

Frequently asked questions

  • May I import a medicine authorised in the EU into Switzerland?

    Only if it is also authorised in Switzerland or an exception applies, such as an individual import by a healthcare professional under Art. 49 MPLO or a parallel import with a simplified authorisation.

  • What is a parallel import?

    The import by a third party of a medicinal product authorised in Switzerland from another market. It requires a simplified authorisation under Art. 14 para. 2 TPA and, because the product is repackaged, a manufacturing licence.

  • Do I need import testing for goods from third countries?

    Generally yes, unless it can be shown that equivalent controls have already been carried out in the EEA or Switzerland. The scope is determined on a risk basis.

  • May a private individual import medicinal products?

    For personal use in small quantities, roughly a month's supply, and not for narcotics or prohibited products. Resale is excluded.

  • How long does an export certificate take?

    Plan for two to six weeks from a complete application. With several destination countries, a bundled application is worthwhile.

Sources

Last updated:

Read next

Planning an authorisation or a licence?

Describe your question or support needs. Your enquiry reaches the website operator. Specialist services are delivered by separately appointed providers; forwarding requires your consent.

  • Independent publishing
  • Public sources
  • Swiss market focus
  • Eight website languages
Send an enquiry
Does this apply to your product?Send an enquiry

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissregulatoryguide.com